Bupropion for the treatment of apathy in Huntington’s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial

OBJECTIVE: To evaluate the efficacy and safety of bupropion in the treatment of apathy in Huntington’s disease (HD). METHODS: In this phase 2b multicentre, double-blind, placebo-controlled crossover trial, individuals with HD and clinical signs of apathy according to the Structured Clinical Intervie...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelderblom, Harald, Wüstenberg, Torsten, McLean, Tim, Mütze, Lisanne, Fischer, Wilhelm, Saft, Carsten, Hoffmann, Rainer, Süssmuth, Sigurd, Schlattmann, Peter, van Duijn, Erik, Landwehrmeyer, Bernhard, Priller, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360242/
https://www.ncbi.nlm.nih.gov/pubmed/28323838
http://dx.doi.org/10.1371/journal.pone.0173872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360242/
https://www.ncbi.nlm.nih.gov/pubmed/28323838
http://dx.doi.org/10.1371/journal.pone.0173872

Ejemplares similares